|
|
CrossRef Text and Data Mining | |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty | |
You Jin Kim, Hae Sang Lee, Young Jun Lee, Jung Sub Lim, Se Young Kim, Eun Young Kim, Dong Kyu Jin, Il Tae Hwang, Jin Soon Hwang | |
Ann Pediatr Endocrinol Metab. 2013;18(4):173-178. Published online December 31, 2013 DOI: https://doi.org/10.6065/apem.2013.18.4.173 |
|
Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study Two-year results of treatment with depot leuprolide acetate for central precocious puberty MP-18.07: Phase III Efficacy and Safety Trial of a New Leuprolide Acetate 3.75 Mg Depot Formulation in Prostate Cancer Patients A Randomized Trial of 1- and 3-Month Depot Leuprolide Doses in the Treatment of Central Precocious Puberty Local reactions to depot leuprolide therapy for central precocious puberty Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center Corrigendum to: “Phase 3 Trial of a Small-Volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty” |